Unlock instant, AI-driven research and patent intelligence for your innovation.

Dioxane modified tetrahydrocarboline-3-formyl-The-EDG, and preparation, anti-metastasis activity and application of dioxane modified tetrahydrocarboline-3-formyl-The-EDG

A dioxane, -the-glu-asp-gly technology, applied in the preparation methods of peptides, organic active ingredients, medical preparations of non-active ingredients, etc., can solve the problems of multidrug resistance and cancer treatment. Difficulties, Expensive Treatment Prices, etc.

Active Publication Date: 2021-06-18
CAPITAL UNIVERSITY OF MEDICAL SCIENCES
View PDF10 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, due to serious side effects, multidrug resistance after drug treatment and expensive treatment prices, cancer treatment is once again in trouble

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Dioxane modified tetrahydrocarboline-3-formyl-The-EDG, and preparation, anti-metastasis activity and application of dioxane modified tetrahydrocarboline-3-formyl-The-EDG
  • Dioxane modified tetrahydrocarboline-3-formyl-The-EDG, and preparation, anti-metastasis activity and application of dioxane modified tetrahydrocarboline-3-formyl-The-EDG
  • Dioxane modified tetrahydrocarboline-3-formyl-The-EDG, and preparation, anti-metastasis activity and application of dioxane modified tetrahydrocarboline-3-formyl-The-EDG

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0022] Example 1 Preparation (3S) -1, 1-dihydroxymethyl-tetrahydro-β-kethane-3-carboxylate (1)

[0023] 2 g (7.2 mmol) of L-tryptophan benzyl ester was added to 10 ml of dichloromethane, and thoroughly stirred it. Under ice bath, 1 ml of trifluoroacetic acid was slowly added dropwise. Then, 0.78 g (8.6 mmol) 1,3-dihydroxyacetone was added to the solution, and the room temperature was reacted for 7 hours. TLC showed L-tryptophan benzyl disappearance (dichloromethane / methanol: 30: 1). Under ice bath, 50ml saturated NaHCO is added to the solution 3 Solution, stir well, then leave a dichloromethane layer, then use saturated NaHCO 3 Solution (30 mL × 3) washing, then washed with saturated NaCl (30 ml × 3), dried over anhydrous sodium sulfate for 12 hours with anhydrous sodium sulfate. Filtration, the filtrate was concentrated to give 2.03 g (77%) title compound to be a yellow powder. ESI-MS (M / E): 367 [M + H] + .

Embodiment 2

[0024] Example 2 Preparation 3S-1- (1,1-dimethyl-1,3-dioxane-6-) -1,2,3,4-tetrahydro-β-β-β-β-β-3- Benzyl carboxylate (2)

[0025] 0.2 g (0.55 mmol) (3S) -1,1-dihydroxymethyl-tetrahydro-β-p-3-carboxylate (1) was added to 5 ml anhydrous acetone. Under ice bath, 100 μl of concentrated sulfuric acid was added, and then stirred at room temperature for 3 hours. The TLC showed the compound 1 disappeared (petroleum ether / ethyl acetate, 4: 1). Under ice bath, with saturated NAHCO 3 The solution regulates the reaction liquid pH of 7, and the resulting solution was concentrated under reduced pressure, and the residue was then raised by ethyl acetate, and the ethyl acetate layer was washed to neutral with a saturated NaCl solution. Ethyl acetate layer was dried over anhydrous sodium sulfate for 12 hours. Filtration, the filtrate was concentrated under reduced pressure, separated from the column chromatography (EtOAc EtOAc) EtOAc (35.8%) ESI-MS (M / E): 407 [M + H] + .

Embodiment 3

[0026] Example 3 Preparation 3S-1- (1, 1-dimethyl-1,3-dioxane-6-) -1,2,3,4-tetrahydro-β-β-β-β-3- Carboxylic acid (3)

[0027] 0.20 g (0.5 mmol) of 3S-1- (1,1-dimethyl-1,3-dioxane-6-spiro) -1, 2, 3, 4-tetrahydrogen - β-p-3-carboxylate (2) and 0.02 g of Pd / c. The mixture was stirred and passed by hydrogen, TLC showed compound 2 disappeared (petroleum ether / ethyl acetate, 4: 1). Palladium carbon (PD / C) was removed by filtration, and the filtrate was concentrated under reduced pressure. The residue was washed with diethyl ether to give 0.14 g (90%) title compound for colorless solids. ESI-MS (M / E): 317 [M + H] + .

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses 3S-1-(1,1-dimethyl-1,3-dioxane-6-spiroyl)-1,2,3,4-tetrahydro-beta-carboline-3-formyl-The-Glu-Asp-Gly as shown in the following formula, discloses a preparation method of the 3S-1-(1,1-dimethyl-1,3-dioxane-6-spiroyl)-1,2,3,4-tetrahydro-beta-carboline-3-formyl-The-Glu-Asp-Gly, and discloses anti-tumor metastasis activity of the 3S-1-(1,1-dimethyl-1,3-dioxane-6-spiroyl)-1,2,3,4-tetrahydro-beta-carboline-3-formyl-The-Glu-Asp-Gly. Therefore, the invention discloses application of the 3S-1-(1,1-dimethyl-1,3-dioxane-6-spiroyl)-1,2,3,4-tetrahydro-beta-carboline-3-formyl-The-Glu-Asp-Gly to preparation of anti-tumor metastasis drugs.

Description

Technical field [0001] The present invention relates to 3S-1- (1, 1-dimethyl-1,3-dioxane-6-spiral) -1, 2, 3, 4-tetrahydro-β-β-pyrid-3-A The compound of acyl-The-Glu-ASP-GLY is related to its preparation method involves its anti-tumor transfer activity. The present invention is therefore related to the application of the compound in an anti-tumor metastatic drug. [0002] Background technique [0003] Tumors have become a common disease that seriously threatens human health. For example, the new tumor patients in 2015 approximately 39.29 million, of which 233.8 million tumor patients died. Average more than 10,000 people were diagnosed with tumors per day. At present, the method of treating cancer is mainly radiopathic, chemotherapy, antibody therapy and immunotherapy. However, due to severe side effects, multiple drug resistance and expensive treatment prices after drug treatment, so that the treatment of cancer is still in trouble. The invention of new types of anti-tumor drug...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): C07K7/06C07K1/02A61K31/438A61K47/64A61P35/04
CPCC07K7/06A61P35/04A61K38/00
Inventor 赵明彭师奇郤思远
Owner CAPITAL UNIVERSITY OF MEDICAL SCIENCES